These data are in agreement with the reduced calcification in CCD cells demonstrated by Alizarin red staining, suggesting that RUNX2 dysregulation prevents osteogenic maturation by reducing p53 levels too. This evidence concerns the gene RUNX2 and cleidocranial dysplasia 1.